BioCentury
ARTICLE | Company News

ProteoTech other research news

April 19, 1999 7:00 AM UTC

ProteoTech received two Phase I SBIR grants totaling $371,487 from the National Institute of Aging, one to isolate and identify the ingredients in its PTI-00703 plant extract that inhibits the formation of amyloid protein deposits, which are thought to be involved in AD, and the other to study a structural feature of the carbohydrate portion of proteoglycans thought to enhance the formation of amyloid plaques and neurofibrillary tangles, both features of AD. Separately, ProteoTech and colleagues published the proteoglycan data in the Journal of Neurochemistry. ...